Physician profile
Charles Ruzkowski
NPI 1669576757
$4,650.08
in general payments reported to CMS, 2019-2025
16 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $372 · 2021: $1,164 · 2022: $321 · 2023: $1,418 · 2024: $136 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,198 · Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,197.76 |
| Food and Beverage | $516.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,451.63 | 2019-2024 | Spyglass, Exalt Model D |
| Abbvie INC. | $757.89 | 2019-2022 | |
| Gilead Sciences, INC. | $370.57 | 2019-2025 | Epclusa |
| Janssen Biotech, INC. | $229.37 | 2019-2023 | Stelara |
| Pfizer INC. | $201.55 | 2019 | |
| Intercept Pharmaceuticals, INC. | $164.85 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $156.36 | 2019-2024 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.10 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $36.27 | 2019-2020 | |
| Grifols USA, LLC | $29.39 | 2020 | |
| Nestle Healthcare Nutrition INC. | $22.71 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $20.67 | 2022 | |
| Exact Sciences Corporation | $19.34 | 2025 | The Cologuard Plus Collection Kit |
| Organon LLC | $15.14 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.29 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Ruzkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.